| Initial public issue of 18,12,800 equity shares of Rs. 10/- each ("Equity Shares") of Aristo Bio-Tech and Lifescience Limited ("ABLL" or the "Company" or the "Issuer") for cash at a price of Rs. 72/- per equity share including a share premium of Rs. 62/- per equity share (the "Issue Price"), aggregating to Rs. 13.05 crores ("The Issue"), of which 91,200 equity shares of Rs. 10/- each for cash at a price of Rs. 72/- per equity share including a share premium of Rs. 62/- per equity share aggregating to Rs. 0.66 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less market maker reservation portion i.e. issue of 17,21,600 equity shares of Rs. 10/- each including a share premium of Rs. 62/- per equity share aggregating to Rs. 12.40 crores is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 26.63% and 25.29%, respectively of the post issue paid up equity share capital of the company.
The face value of the equity share is Rs. 10/- and the issue price is
Rs. 72/- the issue price is 7.2 times of the face value.
Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter.
|